Butterfly Network (BFLY) Return on Invested Capital (2021 - 2022)
Butterfly Network (BFLY) reported Return on Invested Capital of 56.46% for Q2 2022, down 4674.0% on a YoY basis from 1.23% in Q2 2021, and down 100.37% sequentially from 28.18% in Q1 2022.
Butterfly Network (BFLY) Return on Invested Capital (2021 - 2022) Analysis & Trends
Butterfly Network (BFLY) has 2 years of Return on Invested Capital data on file, last reported at 56.46% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 0.00% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.00% |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -56.46% |
| Mar 31, 2022 | -28.18% |
| Dec 31, 2021 | -11.45% |
| Sep 30, 2021 | -7.34% |
| Jun 30, 2021 | -9.72% |
| Mar 31, 2021 | -7.46% |